Lower House approves bills to raise out-of-pocket costs for OTC-like drugs

Japan's Lower House has approved bills that will increase out-of-pocket costs for certain medications with effects similar to over-the-counter drugs, effective March 2027. The move aims to reduce public health insurance expenditures on widely available drug types. The legislation now moves forward for further review and potential enactment. Final approval is expected after debate in the Upper House.